Interferon signalling in pancreatic beta cells

Frontiers in Bioscience

Volumn 14, Issue 2, 2009, Pages 644-656

  Thomas, Helen E ^a,b   Graham, Kate L ^a   Angstetra, Eveline ^a   McKenzie, Mark D ^a   Dudek, Nadine L ^a   Kay, Thomas W ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Autoimmunity; Beta cell; Interferons; NOD mouse; Review; Type 1 diabetes

Indexed keywords

INTERFERON; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL; CD4+ T LYMPHOCYTE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; PANCREAS ISLET; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; HUMANS; INTERFERONS; ISLETS OF LANGERHANS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 63849167819     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3270     Document Type: Review

References (109)

1. Serreze, D. V. & E. H. Leiter: Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr Opin Immunol, 6, 900-6(1994)
2. Augstein, P., A. G. Elefanty, J. Allison & L. C. Harrison: Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamideaccelerated diabetes. Diabetologia, 41, 1381-8(1998) (Pubitemid 28488768)
3. Kurrer, M. O., S. V. Pakala, H. L. Hanson & J. D. Katz: Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci U S A, 94, 213-8(1997) (Pubitemid 27027189)
4. Moriwaki, M., N. Itoh, J. Miyagawa, K. Yamamoto, A. Imagawa, K. Yamagata, H. Iwahashi, H. Nakajima, M. Namba, S. Nagata, T. Hanafusa & Y. Matsuzawa: Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus. Diabetologia, 42, 1332-40(1999) (Pubitemid 29500970)
5. O'Brien, B. A., B. V. Harmon, D. P. Cameron & D. J. Allan: Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes, 46, 750-7(1997) (Pubitemid 27188250)
6. Emamaullee, J. A. & A. M. Shapiro: Interventional strategies to prevent beta-cell apoptosis in islet transplantation. Diabetes, 55, 1907-14(2006) (Pubitemid 44509961)
7. Thomas, H. E. & T. W. Kay: Beta cell destruction in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Diabetes Metab Res Rev, 16, 251-61. (2000) (Pubitemid 30611785)
8. Jansen, A., F. Homo-Delarche, H. Hooijkaas, P. J. Leenen, M. Dardenne & H. A. Drexhage: Immunohistochemical characterization of monocytesmacrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes, 43, 667-75(1994) (Pubitemid 24138780)
9. Harada, M. & S. Makino: Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1, 2 antibody. Jikken Dobutsu, 35, 501-4(1986)
10. Makino, S., M. Harada, Y. Kishimoto & Y. Hayashi: Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background. Jikken Dobutsu, 35, 495-8(1986)
11. Wicker, L. S., B. J. Miller & Y. Mullen: Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes, 35, 855-60(1986) (Pubitemid 16014435)
12. Yagi, H., M. Matsumoto, K. Kunimoto, J. Kawaguchi, S. Makino & M. Harada: Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J Immunol, 22, 2387-93(1992)
13. Bottazzo, G. F., B. M. Dean, J. M. McNally, E. H. MacKay, P. G. Swift & D. R. Gamble: In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med, 313, 353-60(1985) (Pubitemid 15046367)
14. Haskins, K. & D. Wegmann: Diabetogenic T-cell clones. Diabetes, 45, 1299-305(1996) (Pubitemid 26332890)
15. Verdaguer, J., D. Schmidt, A. Amrani, B. Anderson, N. Averill & P. Santamaria: Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med, 186, 1663-76(1997) (Pubitemid 27506280)
16. Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel & H. Hengartner: Molecular mechanisms of lymphocytemediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol, 14, 207-32(1996) (Pubitemid 26130183)
17. Mandrup-Poulsen, T., K. Bendtzen, J. Nerup, C. A. Dinarello, M. Svenson & J. H. Nielsen: Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia, 29, 63-7(1986) (Pubitemid 16162744)
18. Eizirik, D. L. & T. Mandrup-Poulsen: A choice of death-the signal-transduction of immune-mediated betacell apoptosis. Diabetologia, 44, 2115-33(2001) (Pubitemid 34015464)
19. Darnell, J. E., Jr., I. M. Kerr & G. R. Stark: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 264, 1415-21(1994) (Pubitemid 24217131)
20. Pestka, S., C. D. Krause & M. R. Walter: Interferons, interferon-like cytokines, and their receptors. Immunol Rev, 202, 8-32(2004) (Pubitemid 39576902)
21. Platanias, L. C.: Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol, 5, 375-86(2005)
22. Uddin, S., B. Majchrzak, J. Woodson, P. Arunkumar, Y. Alsayed, R. Pine, P. R. Young, E. N. Fish & L. C. Platanias: Activation of the p38 mitogen-activated protein kinase by type I interferons. J Biol Chem, 274, 30127-31(1999)
23. Uddin, S., L. Yenush, X. J. Sun, M. E. Sweet, M. F. White & L. C. Platanias: Interferon-alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3'-kinase. J Biol Chem, 270, 15938-41(1995)
24. Varinou, L., K. Ramsauer, M. Karaghiosoff, T. Kolbe, K. Pfeffer, M. Muller & T. Decker: Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity. Immunity, 19, 793-802(2003) (Pubitemid 37542300)
25. Honda, K. & T. Taniguchi: IRFs: master regulators of signalling by Toll-like receptors and cytosolic patternrecognition receptors. Nat Rev Immunol, 6, 644-58(2006) (Pubitemid 44298214)
26. Taniguchi, T., K. Ogasawara, A. Takaoka & N. Tanaka: IRF family of transcription factors as regulators of host defense. Annu Rev Immunol, 19, 623-55(2001) (Pubitemid 32368048)
27. Alexander, W. S. & D. J. Hilton: The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol, 22, 503-29(2004) (Pubitemid 38680432)
28. Kovanen, P. E. & W. J. Leonard: Inhibitors keep cytokines in check. Curr Biol, 9, R899-902 (1999)
29. Yoshimura, A., T. Naka & M. Kubo: SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol, 7, 454-65(2007) (Pubitemid 46834848)
30. Shuai, K.: Regulation of cytokine signaling pathways by PIAS proteins. Cell Res, 16, 196-202(2006) (Pubitemid 43247977)
31. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, T. Miyazaki, N. Leonor, T. Taniguchi, T. Fujita, Y. Kanakura, S. Komiya & A. Yoshimura: A new protein containing an SH2 domain that inhibits JAK kinases. Nature, 387, 921-4(1997) (Pubitemid 27289595)
32. Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, S. Akira & T. Kishimoto: Structure and function of a new STAT-induced STAT inhibitor. Nature, 387, 924-9(1997) (Pubitemid 27289596)
33. Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola & D. J. Hilton: A family of cytokineinducible inhibitors of signalling. Nature, 387, 917-21(1997)
34. Naka, T., T. Matsumoto, M. Narazaki, M. Fujimoto, Y. Morita, Y. Ohsawa, H. Saito, T. Nagasawa, Y. Uchiyama & T. Kishimoto: Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc Natl Acad Sci U S A, 95, 15577-82(1998) (Pubitemid 29018741)
35. Starr, R., D. Metcalf, A. G. Elefanty, M. Brysha, T. A. Willson, N. A. Nicola, D. J. Hilton & W. S. Alexander: Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc Natl Acad Sci U S A, 95, 14395-9(1998) (Pubitemid 28549378)
36. Alexander, W. S., R. Starr, J. E. Fenner, C. L. Scott, E. Handman, N. S. Sprigg, J. E. Corbin, A. L. Cornish, R. Darwiche, C. M. Owczarek, T. W. H. Kay, N. A. Nicola, P. J. Hertzog, D. Metcalf & D. J. Hilton: SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell, 98, 597-608(1999) (Pubitemid 29418951)
37. Marine, J.-C., D. J. Topham, C. McKay, D. Wang, E. Parganas, D. Stravopodis, A. Yoshimura & J. N. Ihle: SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell, 98, 609-16(1999) (Pubitemid 29418952)
38. Campbell, I. L., L. Oxbrow, J. West & L. C. Harrison: Regulation of MHC protein expression in pancreatic betacells by interferon-gamma and tumor necrosis factor-alpha. Mol Endocrinol, 2, 101-7(1988) (Pubitemid 18080058)
39. Stassi, G., M. Todaro, P. Richiusa, M. Giordano, A. Mattina, M. S. Sbriglia, A. Lo Monte, G. Buscemi, A. Galluzzo & C. Giordano: Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human beta-cells sorted by flowcytometry and cultured in vitro. Transplant Proc, 27, 3271-5(1995) (Pubitemid 26016176)
40. Christen, U., D. B. McGavern, A. D. Luster, M. G. von Herrath & M. B. Oldstone: Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol, 171, 6838-45(2003) (Pubitemid 37532119)
41. Eizirik, D. L., M. Flodstrom, A. E. Karlsen & N. Welsh: The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia, 39, 875-90(1996) (Pubitemid 26249106)
42. Reddy, S., S. Kaill, C. A. Poole & J. Ross: Inducible nitric oxide synthase in pancreatic islets of the non-obese diabetic mouse: a light and confocal microscopical study of its ontogeny, co-localization and up-regulation following cytokine administration. Histochem J, 29, 53-64(1997) (Pubitemid 27173648)
43. Chong, M. M., H. E. Thomas & T. W. Kay: gamma-Interferon Signaling in Pancreatic beta-Cells Is Persistent but Can Be Terminated by Overexpression of Suppressor of Cytokine Signaling-1. Diabetes, 50, 2744-51. (2001) (Pubitemid 33733125)
44. Santangelo, C., A. Scipioni, L. Marselli, P. Marchetti & F. Dotta: Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines. Eur J Endocrinol, 152, 485-9(2005) (Pubitemid 40439503)
45. Foulis, A. K., M. A. Farquharson & A. Meager: Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet, 2, 1423-7. (1987) (Pubitemid 18010318)
46. Rabinovitch, A., W. Suarez-Pinzon, A. El-Sheikh, O. Sorensen & R. F. Power: Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: expression of Th1 cytokines correlates with beta-cell destructive insulitis and IDDM. Diabetes, 45, 749-54(1996) (Pubitemid 26166770)
47. Rabinovitch, A., W. L. Suarez-Pinzon, O. Sorensen, R. C. Bleackley & R. F. Power: IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol, 154, 4874-82(1995)
48. Devendra, D. & G. S. Eisenbarth: Interferon alpha - a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin Immunol, 111, 225-33(2004) (Pubitemid 38739316)
49. Stewart, T. A.: Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases. Cytokine Growth Factor Rev, 14, 139-54(2003) (Pubitemid 36389527)
50. Theofilopoulos, A. N., R. Baccala, B. Beutler & D. H. Kono: Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol, 23, 307-36(2005) (Pubitemid 40563172)
51. Toms, G. C., P. Baker & B. J. Boucher: The production of immunoreactive alpha-and gamma-interferon by circulating mononuclear cells in type 1 diabetes. Diabet Med, 8, 547-50(1991)
52. Huang, X., J. Yuang, A. Goddard, A. Foulis, R. F. James, A. Lernmark, R. Pujol-Borrell, A. Rabinovitch, N. Somoza & T. A. Stewart: Interferon expression in the pancreases of patients with type I diabetes. Diabetes, 44, 658-64(1995)
53. Stewart, T. A., B. Hultgren, X. Huang, S. Pitts-Meek, J. Hully & N. J. MacLachlan: Induction of type I diabetes by interferon-alpha in transgenic mice. Science, 260, 1942-6. (1993) (Pubitemid 23258275)
54. Pelegrin, M., J. C. Devedjian, C. Costa, J. Visa, G. Solanes, A. Pujol, G. Asins, A. Valera & F. Bosch: Evidence from transgenic mice that interferon-beta may be involved in the onset of diabetes mellitus. J Biol Chem, 273, 12332-40(1998) (Pubitemid 28240602)
55. Vassileva, G., S. C. Chen, M. Zeng, S. Abbondanzo, K. Jensen, D. Gorman, B. M. Baroudy, Y. Jiang, N. Murgolo & S. A. Lira: Expression of a novel murine type I IFN in the pancreatic islets induces diabetes in mice. J Immunol, 170, 5748-55(2003) (Pubitemid 36617868)
56. Huang, X., B. Hultgren, N. Dybdal & T. A. Stewart: Islet expression of interferon-alpha precedes diabetes in both the BB rat and streptozotocin-treated mice. Immunity, 1, 469-78(1994)
57. Moriyama, H., L. Wen, N. Abiru, E. Liu, L. Yu, D. Miao, R. Gianani, F. S. Wong & G. S. Eisenbarth: Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc Natl Acad Sci U S A, 99, 5539-44(2002) (Pubitemid 34411584)
58. Sobel, D. O., J. Newsome, C. H. Ewel, J. A. Bellanti, V. Abbassi, K. Creswell & O. Blair: Poly I:C induces development of diabetes mellitus in BB rat. Diabetes, 41, 515-20(1992)
59. Serreze, D. V., K. Hamaguchi & E. H. Leiter: Immunostimulation circumvents diabetes in NOD/Lt mice. J Autoimmun, 2, 759-76(1989)
60. Tanaka-Kataoka, M., T. Kunikata, S. Takayama, K. Iwaki, M. Fujii, K. Ohashi, M. Ikeda & M. Kurimoto: Oral use of interferon-alpha delays the onset of insulindependent diabetes mellitus in nonobese diabetes mice. J Interferon Cytokine Res, 19, 877-9(1999) (Pubitemid 29406641)
61. Brod, S. A.: Ingested type I interferon: state of the art as treatment for autoimmunity. Exp Biol Med (Maywood), 227, 981-8(2002) (Pubitemid 36008305)
62. Hultgren, B., X. Huang, N. Dybdal & T. A. Stewart: Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes, 45, 812-7(1996) (Pubitemid 26166778)
63. Serreze, D. V., C. M. Post, H. D. Chapman, E. A. Johnson, B. Lu & P. B. Rothman: Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes, 49, 2007-11(2000)
64. Wang, B., I. Andre, A. Gonzalez, J. D. Katz, M. Aguet, C. Benoist & D. Mathis: Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc Natl Acad Sci U S A, 94, 13844-9(1997) (Pubitemid 28009672)
65. Kanagawa, O., G. Xu, A. Tevaarwerk & B. A. Vaupel: Protection of nonobese diabetic mice from diabetes by gene (s) closely linked to IFN-gamma receptor loci. J Immunol, 164, 3919-23(2000) (Pubitemid 30169852)
66. Savinov, A. Y., F. S. Wong & A. V. Chervonsky: IFN-gamma Affects Homing of Diabetogenic T Cells. J Immunol, 167, 6637-43. (2001) (Pubitemid 33081602)
67. Chong, M. M., Y. Chen, R. Darwiche, N. L. Dudek, W. Irawaty, P. Santamaria, J. Allison, T. W. Kay & H. E. Thomas: Suppressor of Cytokine Signaling-1 Overexpression Protects Pancreatic beta Cells from CD8 (+) T Cell-Mediated Autoimmune Destruction. J Immunol, 172, 5714-5721(2004) (Pubitemid 38542076)
68. Thomas, H. E., J. L. Parker, R. D. Schreiber & T. W. Kay: IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J Clin Invest, 102, 1249-57(1998) (Pubitemid 28436285)
69. Brode, S., T. Raine, P. Zaccone & A. Cooke: Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J Immunol, 177, 6603-12(2006) (Pubitemid 44715023)
70. Campbell, I. L., L. Oxbrow & L. C. Harrison: Reduction in insulitis following administration of IFN-gamma and TNF-alpha in the NOD mouse. J Autoimmun, 4, 249-62(1991)
71. Debray-Sachs, M., C. Carnaud, C. Boitard, H. Cohen, I. Gresser, P. Bedossa & J. F. Bach: Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun, 4, 237-48(1991)
72. Kay, T. W., I. L. Campbell, L. Oxbrow & L. C. Harrison: Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by antiinterferon-gamma antibody. Diabetologia, 34, 779-85(1991)
73. Gysemans, C. A., L. Ladriere, H. Callewaert, J. Rasschaert, D. Flamez, D. E. Levy, P. Matthys, D. L. Eizirik & C. Mathieu: Disruption of the gamma-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of beta-cells. Diabetes, 54, 2396-403(2005) (Pubitemid 41134268)
74. Kim, S., H. S. Kim, K. W. Chung, S. H. Oh, J. W. Yun, S. H. Im, M. K. Lee, K. W. Kim & M. S. Lee: Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice. Diabetes, 56, 2561-8(2007) (Pubitemid 47523264)
75. Nakazawa, T., J. Satoh, K. Takahashi, Y. Sakata, F. Ikehata, Y. Takizawa, S. I. Bando, T. Housai, Y. Li, C. Chen, T. Masuda, S. Kure, I. Kato, S. Takasawa, T. Taniguchi, H. Okamoto & T. Toyota: Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1. J Autoimmun, 17, 119-25(2001) (Pubitemid 32928207)
76. Fallarino, F. & T. F. Gajewski: Cutting edge: differentiation of antitumor CTL in vivo requires host expression of Stat1. J Immunol, 163, 4109-13(1999) (Pubitemid 29474472)
77. Katz, J., C. Benoist & D. Mathis: Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur J Immunol, 23, 3358-60(1993) (Pubitemid 23353790)
78. Sumida, T., M. Furukawa, A. Sakamoto, T. Namekawa, T. Maeda, M. Zijlstra, I. Iwamoto, T. Koike, S. Yoshida, H. Tomioka & et al.: Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice. Int Immunol, 6, 1445-9(1994) (Pubitemid 24296861)
79. Serreze, D. V., E. H. Leiter, G. J. Christianson, D. Greiner & D. C. Roopenian: Major histocompatibility complex class I-deficient NOD-beta 2-m null mice are diabetes and insulitis resistant. Diabetes, 43, 505-9(1994)
80. Wicker, L. S., E. H. Leiter, J. A. Todd, R. J. Renjilian, E. Peterson, P. A. Fischer, P. L. Podolin, M. Zijlstra, R. Jaenisch & L. B. Peterson: Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes, 43, 500-4(1994) (Pubitemid 24064260)
81. Kay, T. W., J. L. Parker, L. A. Stephens, H. E. Thomas & J. Allison: RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice. J Immunol, 157, 3688-93(1996) (Pubitemid 126449185)
82. Hamilton-Williams, E. E., S. E. Palmer, B. Charlton & R. M. Slattery: Beta cell MHC class I is a late requirement for diabetes. Proc Natl Acad Sci U S A, 100, 6688-93(2003) (Pubitemid 36666642)
83. Yamanouchi, J., J. Verdaguer, B. Han, A. Amrani, P. Serra & P. Santamaria: Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens. J Immunol, 171, 6900-9(2003) (Pubitemid 37532126)
84. Campbell, I. L., L. Oxbrow, M. Koulmanda & L. C. Harrison: IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J Immunol, 140, 1111-6(1988) (Pubitemid 18088575)
85. Dudek, N. L., H. E. Thomas, L. Mariana, R. M. Sutherland, J. Allison, E. Estella, E. Angstetra, J. A. Trapani, P. Santamaria, A. M. Lew & T. W. Kay: Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways. Diabetes, 55, 2412-8(2006) (Pubitemid 44871141)
86. Darwiche, R., M. M. Chong, P. Santamaria, H. E. Thomas & T. W. Kay: Fas is detectable on beta cells in accelerated, but not spontaneous, diabetes in nonobese diabetic mice. J Immunol, 170, 6292-7(2003) (Pubitemid 36682615)
87. Flodstrom-Tullberg, M., D. Yadav, R. Hagerkvist, D. Tsai, P. Secrest, A. Stotland & N. Sarvetnick: Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse. Diabetes, 52, 2696-700(2003) (Pubitemid 37339699)
88. Solomon, M., M. Flodstrom-Tullberg & N. Sarvetnick: Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice. Transplantation, 79, 1104-9(2005) (Pubitemid 40664005)
89. Chong, M. M., H. E. Thomas & T. W. Kay: Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic beta cells to tumor necrosis factor. J Biol Chem, 277, 27945-52(2002) (Pubitemid 34966742)
90. Karlsen, A. E., S. G. Ronn, K. Lindberg, J. Johannesen, E. D. Galsgaard, F. Pociot, J. H. Nielsen, T. Mandrup-Poulsen, J. Nerup & N. Billestrup: Suppressor of cytokine signaling 3 (SOCS-3) protects beta-cells against interleukin-1beta - and interferon-gamma-mediated toxicity. Proc Natl Acad Sci U S A, 98, 12191-6(2001) (Pubitemid 32959849)
91. Frobose, H., S. G. Ronn, P. E. Heding, H. Mendoza, P. Cohen, T. Mandrup-Poulsen & N. Billestrup: Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol Endocrinol, 20, 1587-96(2006) (Pubitemid 43967566)
92. Flodstrom-Tullberg, M., M. Hultcrantz, A. Stotland, A. Maday, D. Tsai, C. Fine, B. Williams, R. Silverman & N. Sarvetnick: RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J Immunol, 174, 1171-7(2005)
93. Horwitz, M. S., C. Fine, A. Ilic & N. Sarvetnick: Requirements for viral-mediated autoimmune diabetes: betacell damage and immune infiltration. J Autoimmun, 16, 211-7(2001) (Pubitemid 32566109)
94. Hyoty, H. & K. W. Taylor: The role of viruses in human diabetes. Diabetologia, 45, 1353-61(2002) (Pubitemid 35244887)
95. Roivainen, M.: Enteroviruses: new findings on the role of enteroviruses in type 1 diabetes. Int J Biochem Cell Biol, 38, 721-5(2006) (Pubitemid 43363408)
96. Flodstrom, M., A. Maday, D. Balakrishna, M. M. Cleary, A. Yoshimura & N. Sarvetnick: Target cell defense prevents the development of diabetes after viral infection. Nat Immunol, 4, 4(2002)
97. Flodstrom, M., D. Tsai, C. Fine, A. Maday & N. Sarvetnick: Diabetogenic potential of human pathogens uncovered in experimentally permissive beta-cells. Diabetes, 52, 2025-34(2003) (Pubitemid 36919795)
98. Hultcrantz, M., M. H. Huhn, M. Wolf, A. Olsson, S. Jacobson, B. R. Williams, O. Korsgren & M. Flodstrom-Tullberg: Interferons induce an antiviral state in human pancreatic islet cells. Virology, 367, 92-101(2007) (Pubitemid 47418925)
99. Lieberman, S. M., A. M. Evans, B. Han, T. Takaki, Y. Vinnitskaya, J. A. Caldwell, D. V. Serreze, J. Shabanowitz, D. F. Hunt, S. G. Nathenson, P. Santamaria & T. P. DiLorenzo: Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci U S A, 100, 8384-8(2003) (Pubitemid 36842554)
100. Amrani, A., J. Verdaguer, B. Anderson, T. Utsugi, S. Bou & P. Santamaria: Perforin-independent beta-cell destruction by diabetogenic CD8 (+) T lymphocytes in transgenic nonobese diabetic mice. J Clin Invest, 103, 1201-9(1999) (Pubitemid 29207254)
101. McKenzie, M. D., N. L. Dudek, L. Mariana, M. M. Chong, J. A. Trapani, T. W. Kay & H. E. Thomas: Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL. Int Immunol, 18, 837-46(2006) (Pubitemid 43983279)
102. Barral, A. M., H. E. Thomas, E. M. Ling, R. Darwiche, E. Rodrigo, U. Christen, M. Ejrnaes, T. Wolfe, T. W. Kay & M. G. von Herrath: SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes. J Autoimmun, 27, 166-73(2006) (Pubitemid 46048591)
103. Seewaldt, S., H. E. Thomas, M. Ejrnaes, U. Christen, T. Wolfe, E. Rodrigo, B. Coon, B. Michelsen, T. W. H. Kay & M. G. von Herrath: Virus-induced autoimmune diabetes: most beta cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) CTL. Diabetes, 49, 1801-9(2000)
104. von Herrath, M. G. & M. B. Oldstone: Virus-induced autoimmune disease. Curr Opin Immunol, 8, 878-85(1996) (Pubitemid 27007656)
105. von Herrath, M. G. & M. B. Oldstone: Interferongamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus. J Exp Med, 185, 531-9(1997) (Pubitemid 27078371)
106. Lang, K. S., M. Recher, T. Junt, A. A. Navarini, N. L. Harris, S. Freigang, B. Odermatt, C. Conrad, L. M. Ittner, S. Bauer, S. A. Luther, S. Uematsu, S. Akira, H. Hengartner & R. M. Zinkernagel: Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med, 11, 138-45(2005) (Pubitemid 40321348)
107. Andre-Schmutz, I., C. Hindelang, C. Benoist & D. Mathis: Cellular and molecular changes accompanying the progression from insulitis to diabetes. Eur J Immunol, 29, 245-55(1999) (Pubitemid 29043542)
108. Pakala, S. V., M. Chivetta, C. B. Kelly & J. D. Katz: In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J Exp Med, 189, 1053-62(1999) (Pubitemid 29169822)
109. Amrani, A., J. Verdaguer, S. Thiessen, S. Bou & P. Santamaria: IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4 (+) T lymphocytes. J Clin Invest, 105, 459-68(2000) (Pubitemid 30127246)